Jakafi (ruxolitinib) - Incyte
bonretinib (OB756) - Biosun Pharma
https://ashpublications.org/blood/article/146/Supplement%201/7351/553394/Indirect-treatment-comparison-of-novel-JAK2
 
Jian Huang 1; Bingbing Wen 1,2; Tiejun Gong 3; Hu Zhou 4; Qingchi Liu 6; Lihong Shou 5; Feng Zhang 7; Cuicui Wu 8; Wei Yang 9; Lidong Zhao 10; Lili Chen 11; Jian Lu 12; Yile Zhou 1; Yi Zhang 1; Jie Jin 1
 
Dec 5, 2025
 
Next